MCNAMARA JOHN W
Known title: DirectorCIK: 0001470528
Associated companies
Transaction History
| GEF | ▲ Buy | Grant | 2,143 | $0 | 2/23/2026 | View on chart |
| GEF | ▲ Buy | Grant | 2,668 | $0 | 2/24/2025 | View on chart |
| GEF | ▲ Buy | Grant | 2,247 | $0 | 2/26/2024 | View on chart |
| GEF | ▲ Buy | Grant | 2,016 | $0 | 2/28/2023 | View on chart |
| GEF | ▲ Buy | Grant | 2,469 | $0 | 3/1/2022 | View on chart |
| GEF | ▼ Sell | Gift | 25,100 | $0 | 7/21/2017 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Raymond James Upgrades Greif to Outperform with $90 Target
Raymond James upgraded Greif to Outperform and set a price target of $90. This follows Truist Securities maintaining a Hold rating while lowering its target to $94. Additionally, the company's emissions reduction targets were validated by the Science Based Targets initiative. These developments provide a mix of analyst perspectives and sustainability milestones for the stock.
Raymond James Upgrades Greif to Outperform with $90 Target. Raymond James upgraded Greif to Outperform and set a price target of $90. This follows Truist Securities maintaining a Hold rating while lowering its target to $94. Additionally, the company's emissions reduction targets were validated by the Science Based Targets initiative. These developments provide a mix of analyst perspectives and sustainability milestones for the stock.